Literature DB >> 15734438

One-stage unifocalization and palliative right ventricular outflow tract reconstruction.

Takeshi Shinkawa1, Masaaki Yamagishi, Keisuke Shuntoh, Akiyuki Takahashi, Kyoko Hayashida, Nobuo Kitamura.   

Abstract

We report a successful case of one-stage unifocalization concomitant with palliative right ventricular outflow tract reconstruction for pulmonary atresia and ventricular septal defect with major aortopulmonary collateral arteries and central pulmonary arterial absence. Through a median sternotomy, one-stage unifocalization was accomplished using autologous pericardial conduit and no prosthetic material. To achieve an adequate pulmonary blood flow, the right ventricular outflow tract was reconstructed so that it would be 70% of the normal pulmonary annular diameter, while the ventricular septal defect was left open. One-stage unifocalization concomitant with palliative right ventricular outflow tract reconstruction is considered to be a good surgical option for selected patients with these diseases.

Entities:  

Mesh:

Year:  2005        PMID: 15734438     DOI: 10.1016/j.athoracsur.2003.09.109

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Importance of multidisciplinary management for pulmonary atresia, ventricular septal defect, major aorto-pulmonary collateral arteries and completely absent central pulmonary arteries.

Authors:  Takaya Hoashi; Satoshi Yazaki; Koji Kagisaki; Masataka Kitano; Masatoshi Shimada; Isao Shiraishi; Hajime Ichikawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-03-04

Review 2.  Surgical strategies for pulmonary atresia with ventricular septal defect associated with major aortopulmonary collateral arteries.

Authors:  Akio Ikai
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-05-25

3.  Dexmedetomidine attenuates hypoxemia during palliative reconstruction of the right ventricular outflow tract in pediatric patients.

Authors:  Qiang Chen; Wei Wu; Gui-Can Zhang; Hua Cao; Liang-Wan Chen; Yun-Nan Hu; Yan-Dan Chen
Journal:  Medicine (Baltimore)       Date:  2014-09       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.